Artificial intelligence in healthcare

Last updated

X-ray of a hand, with automatic calculation of bone age by a computer software X-ray of hand, where bone age is automatically found by BoneXpert software.jpg
X-ray of a hand, with automatic calculation of bone age by a computer software

Artificial intelligence in healthcare is the application of artificial intelligence (AI) to analyze and understand complex medical and healthcare data. In some cases, it can exceed or augment human capabilities by providing better or faster ways to diagnose, treat, or prevent disease. [1] [2] [3]

Contents

As widespread use of AI in healthcare is relatively new, research is ongoing into its application in various subdisciplines of medicine and related industries. AI programs are applied to practices such as diagnostics, [4] treatment protocol development, [5] drug development, [6] personalized medicine, [7] and patient monitoring and care. [8] Because radiographs are the most common imaging tests conducted in radiology departments, the potential for AI to help with triage and interpretation of radiographs is particularly noteworthy. [9]

Using AI also presents unprecedented ethical concerns related to issues such as data privacy, automation of jobs, and amplifying already existing biases. [10] Furthermore, new technologies such as AI are often resisted by healthcare leaders, leading to slow and erratic adoption. [11] In contrast, there are also several cases where AI has been put to use in healthcare without proper testing. [12] [13] [14] [15] Moreover, meta-studies have found that the scientific literature on AI in healthcare often suffers from a lack of reproducibility. [16] [17] [18] [19]

Applications in healthcare systems

Disease diagnosis

Accurate and early diagnosis of diseases is still a challenge in healthcare. Recognising medical conditions and their symptoms is a complex problem. AI can assist clinicians with its data processing capabilities to save time and improve accuracy. [20] Through the use of machine learning, artificial intelligence can be able to substantially aid doctors in patient diagnosis through the analysis of mass electronic health records (EHRs). [21] AI can help early prediction, for example, of Alzheimer's disease and dementias, by looking through large numbers of similar cases and possible treatments. [22]

Doctors' decision making could also be supported by AI in urgent situations, for example in the emergency department. Here AI algorithms can help prioritize more serious cases and reduce waiting time. Decision support systems augmented with AI can offer real-time suggestions and faster data interpretation to aid the decisions made by healthcare professionals. [20]

In 2023 a study reported higher satisfaction rates with ChatGPT-generated responses compared with those from physicians for medical questions posted on Reddit’s r/AskDocs. [23] Evaluators preferred ChatGPT's responses to physician responses in 78.6% of 585 evaluations, noting better quality and empathy. The authors noted that these were isolated questions taken from an online forum, not in the context of an established patient-physician relationship. [23] Moreover, responses were not graded on the accuracy of medical information, and some have argued that the experiment was not properly blinded, with the evaluators being coauthors of the study. [24] [25] [26]

Recent developments in statistical physics, machine learning, and inference algorithms are also being explored for their potential in improving medical diagnostic approaches. [27]

Electronic health records

Electronic health records (EHR) are crucial to the digitalization and information spread of the healthcare industry. Now that around 80% of medical practices use EHR, some anticipate the use of artificial intelligence to interpret the records and provide new information to physicians. [28]

One application uses natural language processing (NLP) to make more succinct reports that limit the variation between medical terms by matching similar medical terms. [28] For example, the term heart attack and myocardial infarction mean the same things, but physicians may use one over the over based on personal preferences. [28] NLP algorithms consolidate these differences so that larger datasets can be analyzed. [28] Another use of NLP identifies phrases that are redundant due to repetition in a physician's notes and keeps the relevant information to make it easier to read. [28] Other applications use concept processing to analyze the information entered by the current patient's doctor to present similar cases and help the physician remember to include all relevant details. [29]

Beyond making content edits to an EHR, there are AI algorithms that evaluate an individual patient's record and predict a risk for a disease based on their previous information and family history. [30] One general algorithm is a rule-based system that makes decisions similarly to how humans use flow charts. [31] This system takes in large amounts of data and creates a set of rules that connect specific observations to concluded diagnoses. [31] Thus, the algorithm can take in a new patient's data and try to predict the likeliness that they will have a certain condition or disease. [31] Since the algorithms can evaluate a patient's information based on collective data, they can find any outstanding issues to bring to a physician's attention and save time. [30] One study conducted by the Centerstone research institute found that predictive modeling of EHR data has achieved 70–72% accuracy in predicting individualized treatment response. [32] These methods are helpful due to the fact that the amount of online health records doubles every five years. [30] Physicians do not have the bandwidth to process all this data manually, and AI can leverage this data to assist physicians in treating their patients. [30]

Drug interactions

Improvements in natural language processing led to the development of algorithms to identify drug-drug interactions in medical literature. [33] [34] [35] [36] Drug-drug interactions pose a threat to those taking multiple medications simultaneously, and the danger increases with the number of medications being taken. [37] To address the difficulty of tracking all known or suspected drug-drug interactions, machine learning algorithms have been created to extract information on interacting drugs and their possible effects from medical literature. Efforts were consolidated in 2013 in the DDIExtraction Challenge, in which a team of researchers at Carlos III University assembled a corpus of literature on drug-drug interactions to form a standardized test for such algorithms. [38] Competitors were tested on their ability to accurately determine, from the text, which drugs were shown to interact and what the characteristics of their interactions were. [39] Researchers continue to use this corpus to standardize the measurement of the effectiveness of their algorithms. [33] [34] [36]

Other algorithms identify drug-drug interactions from patterns in user-generated content, especially electronic health records and/or adverse event reports. [34] [35] Organizations such as the FDA Adverse Event Reporting System (FAERS) and the World Health Organization's VigiBase allow doctors to submit reports of possible negative reactions to medications. Deep learning algorithms have been developed to parse these reports and detect patterns that imply drug-drug interactions. [40]

Telemedicine

An elderly man using a pulse oximeter to measure his blood oxygen levels Elderly Man Using Pulse Oximeter.jpg
An elderly man using a pulse oximeter to measure his blood oxygen levels

The increase of telemedicine, the treatment of patients remotely, has shown the rise of possible AI applications. [41] AI can assist in caring for patients remotely by monitoring their information through sensors. [42] A wearable device may allow for constant monitoring of a patient and the ability to notice changes that may be less distinguishable by humans. The information can be compared to other data that has already been collected using artificial intelligence algorithms that alert physicians if there are any issues to be aware of. [42]

Another application of artificial intelligence is chat-bot therapy. Some researchers charge that the reliance on chatbots for mental healthcare does not offer the reciprocity and accountability of care that should exist in the relationship between the consumer of mental healthcare and the care provider (be it a chat-bot or psychologist), though. [43]

Since the average age has risen due to a longer life expectancy, artificial intelligence could be useful in helping take care of older populations. [44] Tools such as environment and personal sensors can identify a person's regular activities and alert a caretaker if a behavior or a measured vital is abnormal. [44] Although the technology is useful, there are also discussions about limitations of monitoring in order to respect a person's privacy since there are technologies that are designed to map out home layouts and detect human interactions. [44]

Workload management

AI has the potential to streamline care coordination and reduce the workload. AI algorithms can automate administrative tasks, prioritize patient needs and facilitate seamless communication in a healthcare team. [45] This enables healthcare providers to focus more on direct patient care and ensures the efficient and coordinated delivery of healthcare services.

Clinical applications

Cardiovascular

Artificial intelligence algorithms have shown promising results in accurately diagnosing and risk stratifying patients with concern for coronary artery disease, showing potential as an initial triage tool. [46] [47] Other algorithms have been used in predicting patient mortality, medication effects, and adverse events following treatment for acute coronary syndrome. [46] Wearables, smartphones, and internet-based technologies have also shown the ability to monitor patients' cardiac data points, expanding the amount of data and the various settings AI models can use and potentially enabling earlier detection of cardiac events occurring outside of the hospital. [48] Another growing area of research is the utility of AI in classifying heart sounds and diagnosing valvular disease. [49] Challenges of AI in cardiovascular medicine have included the limited data available to train machine learning models, such as limited data on social determinants of health as they pertain to cardiovascular disease. [50]

A key limitation in early studies evaluating AI were omissions of data comparing algorithmic performance to humans. Examples of studies which assess AI performance relative to physicians includes how AI is non-inferior to humans in interpretation of cardiac echocardiograms [51] and that AI can diagnose heart attack better than human physicians in the emergency setting, reducing both low-value testing and missed diagnoses. [52]

In cardiovascular tissue engineering and organoid studies, AI is increasingly used to analyze microscopy images, and integrate electrophysiological read outs. [53]

Dermatology

Medical imaging (such as X-ray and photography) is a commonly used tool in dermatology [54] and the development of deep learning has been strongly tied to image processing. Therefore, there is a natural fit between the dermatology and deep learning. Machine learning learning holds great potential to process these images for better diagnoses. [55] Han et al. showed keratinocytic skin cancer detection from face photographs. [56] Esteva et al. demonstrated dermatologist-level classification of skin cancer from lesion images. [57] Noyan et al. demonstrated a convolutional neural network that achieved 94% accuracy at identifying skin cells from microscopic Tzanck smear images. [58] A concern raised with this work is that it has not engaged with disparities related to skin color or differential treatment of patients with non-white skin tones. [59]

According to some researchers, AI algorithms have been shown to be more effective than dermatologists at identifying cancer. [60] However, a 2021 review article found that a majority of papers analyzing the performance of AI algorithms designed for skin cancer classification failed to use external test sets. [61] Only four research studies were found in which the AI algorithms were tested on clinics, regions, or populations distinct from those it was trained on, and in each of those four studies, the performance of dermatologists was found to be on par with that of the algorithm. Moreover, only one study [62] was set in the context of a full clinical examination; others were based on interaction through web-apps or online questionnaires, with most based entirely on context-free images of lesions. In this study, it was found that dermatologists significantly outperformed the algorithms. Many articles claiming superior performance of AI algorithms also fail to distinguish between trainees and board-certified dermatologists in their analyses. [61]

It has also been suggested that AI could be used to automatically evaluate the outcome of maxillo-facial surgery or cleft palate therapy in regard to facial attractiveness or age appearance. [63] [64]

Gastroenterology

AI can play a role in various facets of the field of gastroenterology. Endoscopic exams such as esophagogastroduodenoscopies (EGD) and colonoscopies rely on rapid detection of abnormal tissue. By enhancing these endoscopic procedures with AI, clinicians can more rapidly identify diseases, determine their severity, and visualize blind spots. Early trials in using AI detection systems of early stomach cancer have shown sensitivity close to expert endoscopists. [65]

AI can assist doctors treating ulcerative colitis in detecting the microscopic activity of the disease in people and predicting when flare-ups will happen. For example, an AI-powered tool was developed to analyse digitised bowel samples (biopsies). The tool was able to distinguish with 80% accuracy between samples that show remission of colitis and those with active disease. It also predicted the risk of a flare-up happening with the same accuracy. These rates of successfully using microscopic disease activity to predict disease flare are similar to the accuracy of pathologists. [66] [67]

Obstetrics and gynaecology

Artificial intelligence utilises massive amounts of data to help with predicting illness, prevention, and diagnosis, as well as patient monitoring. In obstetrics, artificial intelligence is utilized in magnetic resonance imaging, ultrasound, and foetal cardiotocography. AI contributes in the resolution of a variety of obstetrical diagnostic issues. [68]

Infectious diseases

AI has shown potential in both the laboratory and clinical spheres of infectious disease medicine. [69] During the COVID-19 pandemic, AI has been used for early detection, tracking virus spread and analysing virus behaviour, among other things. [70] However, there were only a few examples of AI being used directly in clinical practice during the pandemic itself. [71]

Other applications of AI around infectious diseases include support-vector machines identifying antimicrobial resistance, machine learning analysis of blood smears to detect malaria, and improved point-of-care testing of Lyme disease based on antigen detection. Additionally, AI has been investigated for improving diagnosis of meningitis, sepsis, and tuberculosis, as well as predicting treatment complications in hepatitis B and hepatitis C patients. [69]

Musculoskeletal

AI has been used to identify causes of knee pain that doctors miss, that disproportionately affect Black patients. [72] Underserved populations experience higher levels of pain. These disparities persist even after controlling for the objective severity of diseases like osteoarthritis, as graded by human physicians using medical images, raising the possibility that underserved patients’ pain stems from factors external to the knee, such as stress. Researchers have conducted a study using a machine-learning algorithm to show that standard radiographic measures of severity overlook objective but undiagnosed features that disproportionately affect diagnosis and management of underserved populations with knee pain. They proposed that new algorithmic measure ALG-P could potentially enable expanded access to treatments for underserved patients. [73]

Neurology

The use of AI technologies has been explored for use in the diagnosis and prognosis of Alzheimer's disease (AD). For diagnostic purposes, machine learning models have been developed that rely on structural MRI inputs. [74] The input datasets for these models are drawn from databases such as the Alzheimer's Disease Neuroimaging Initiative. [75] Researchers have developed models that rely on convolutional neural networks with the aim of improving early diagnostic accuracy. [76] Generative adversarial networks are a form of deep learning that have also performed well in diagnosing AD. [77] There have also been efforts to develop machine learning models into forecasting tools that can predict the prognosis of patients with AD. Forecasting patient outcomes through generative models has been proposed by researchers as a means of synthesizing training and validation sets. [78] They suggest that generated patient forecasts could be used to provide future models larger training datasets than current open access databases.

Oncology

AI has been explored for use in cancer diagnosis, risk stratification, molecular characterization of tumors, and cancer drug discovery. A particular challenge in oncologic care that AI is being developed to address is the ability to accurately predict which treatment protocols will be best suited for each patient based on their individual genetic, molecular, and tumor-based characteristics. [79] AI has been trialed in cancer diagnostics with the reading of imaging studies and pathology slides. [80]

In January 2020, Google DeepMind announced an algorithm capable of surpassing human experts in breast cancer detection in screening scans. [81] [82] A number of researchers, including Trevor Hastie, Joelle Pineau, and Robert Tibshirani among others, published a reply claiming that DeepMind's research publication in Nature lacked key details on methodology and code, "effectively undermin[ing] its scientific value" and making it impossible for the scientific community to confirm the work. [83] In the MIT Technology Review, author Benjamin Haibe-Kains characterized DeepMind's work as "an advertisement" having little to do with science. [84]

In July 2020, it was reported that an AI algorithm developed by the University of Pittsburgh achieves the highest accuracy to date in identifying prostate cancer, with 98% sensitivity and 97% specificity. [85] [86] In 2023 a study reported the use of AI for CT-based radiomics classification at grading the aggressiveness of retroperitoneal sarcoma with 82% accuracy compared with 44% for lab analysis of biopsies. [87] [88]

Ophthalmology

Artificial intelligence-enhanced technology is being used as an aid in the screening of eye disease and prevention of blindness. [89]  In 2018, the U.S. Food and Drug Administration authorized the marketing of the first medical device to diagnose a specific type of eye disease, diabetic retinopathy using an artificial intelligence algorithm. [90] Moreover, AI technology may be used to further improve "diagnosis rates" because of the potential to decrease detection time. [91]

Pathology

Ki67 stain calculation by the open-source software QuPath in a pure seminoma, which gives a measure of the proliferation rate of the tumor. The colors represent the intensity of expression: blue-no expression, yellow-low, orange-moderate, and red-high expression. Ki67 calculation by QuPath in a pure seminoma.png
Ki67 stain calculation by the open-source software QuPath in a pure seminoma, which gives a measure of the proliferation rate of the tumor. The colors represent the intensity of expression: blue-no expression, yellow-low, orange-moderate, and red-high expression.

For many diseases, pathological analysis of cells and tissues is considered to be the gold standard of disease diagnosis. Methods of digital pathology allows microscopy slides to be scanned and digitally analyzed. AI-assisted pathology tools have been developed to assist with the diagnosis of a number of diseases, including breast cancer, hepatitis B, gastric cancer, and colorectal cancer. AI has also been used to predict genetic mutations and prognosticate disease outcomes. [65] AI is well-suited for use in low-complexity pathological analysis of large-scale screening samples, such as colorectal or breast cancer screening, thus lessening the burden on pathologists and allowing for faster turnaround of sample analysis. [93] Several deep learning and artificial neural network models have shown accuracy similar to that of human pathologists, [93] and a study of deep learning assistance in diagnosing metastatic breast cancer in lymph nodes showed that the accuracy of humans with the assistance of a deep learning program was higher than either the humans alone or the AI program alone. [94] Additionally, implementation of digital pathology is predicted to save over $12 million for a university center over the course of five years, [95] though savings attributed to AI specifically have not yet been widely researched. The use of augmented and virtual reality could prove to be a stepping stone to wider implementation of AI-assisted pathology, as they can highlight areas of concern on a pathology sample and present them in real-time to a pathologist for more efficient review. [93] AI also has the potential to identify histological findings at levels beyond what the human eye can see, [93] and has shown the ability to use genotypic and phenotypic data to more accurately detect the tumor of origin for metastatic cancer. [96] One of the major current barriers to widespread implementation of AI-assisted pathology tools is the lack of prospective, randomized, multi-center controlled trials in determining the true clinical utility of AI for pathologists and patients, highlighting a current area of need in AI and healthcare research. [93]

Primary care

Primary care has become one key development area for AI technologies. [97] [98] AI in primary care has been used for supporting decision making, predictive modeling, and business analytics. [99] There are only a few examples of AI decision support systems that were prospectively assessed on clinical efficacy when used in practice by physicians. But there are cases where the use of these systems yielded a positive effect on treatment choice by physicians. [100]

Psychiatry

In psychiatry, AI applications are still in a phase of proof-of-concept. [101] Areas where the evidence is widening quickly include predictive modelling of diagnosis and treatment outcomes, [102] chatbots, conversational agents that imitate human behaviour and which have been studied for anxiety and depression. [103]

Challenges include the fact that many applications in the field are developed and proposed by private corporations, such as the screening for suicidal ideation implemented by Facebook in 2017. [104] Such applications outside the healthcare system raise various professional, ethical and regulatory questions. [105] Another issue is often with the validity and interpretability of the models. Small training datasets contain bias that is inherited by the models, and compromises the generalizability and stability of these models. Such models may also have the potential to be discriminatory against minority groups that are underrepresented in samples. [106]

In 2023, US-based National Eating Disorders Association replaced its human helpline staff with a chatbot but had to take it offline after users reported receiving harmful advice from it. [107] [108] [109]

Radiology

AI is being studied within the field of radiology to detect and diagnose diseases through computerized tomography (CT) and magnetic resonance (MR) imaging. [110] It may be particularly useful in settings where demand for human expertise exceeds supply, or where data is too complex to be efficiently interpreted by human readers. [111] Several deep learning models have shown the capability to be roughly as accurate as healthcare professionals in identifying diseases through medical imaging, though few of the studies reporting these findings have been externally validated. [112] AI can also provide non-interpretive benefit to radiologists, such as reducing noise in images, creating high-quality images from lower doses of radiation, enhancing MR image quality, [113] and automatically assessing image quality. [114] Further research investigating the use of AI in nuclear medicine focuses on image reconstruction, anatomical landmarking, and the enablement of lower doses in imaging studies. [115] The analysis of images for supervised AI applications in radiology encompasses two primary techniques at present: (1) convolutional neural network-based analysis; and (2) utilization of radiomics. [111]

AI is also used in breast imaging for analyzing screening mammograms and can participate in improving breast cancer detection rate [116] as well as reducing radiologist's reading workload.

Pharmacy

This section is an excerpt from Artificial intelligence in pharmacy.[ edit ]
Part of a series on
Artificial intelligence
Dall-e 3 (jan '24) artificial intelligence icon.png
Major goals
Approaches
Applications
Philosophy
History
Glossary
Artificial intelligence in pharmacy is the application of artificial intelligence (AI) [117] [118] [119] to the discovery, development, and the treatment of patients with medications. [120] AI in pharmacy practices has the potential to revolutionize all aspects of pharmaceutical research as well as to improve the clinical application of pharmaceuticals to prevent, treat, or cure disease. [121] AI, a technology that enables machines to simulate human intelligence, has found applications in pharmaceutical research, drug manufacturing, drug delivery systems, clinical trial optimization, treatment plans, and patient-centered services. [122] [123] [124]

Industry

The trend of large health companies merging allows for greater health data accessibility. Greater health data lays the groundwork for the implementation of AI algorithms.

A large part of industry focus of implementation of AI in the healthcare sector is in the clinical decision support systems. As more data is collected, machine learning algorithms adapt and allow for more robust responses and solutions. [110] Numerous companies are exploring the possibilities of the incorporation of big data in the healthcare industry. Many companies investigate the market opportunities through the realms of "data assessment, storage, management, and analysis technologies" which are all crucial parts of the healthcare industry. [125]

The following are examples of large companies that have contributed to AI algorithms for use in healthcare:

Elon Musk premiering the surgical robot that implants the Neuralink brain chip Elon Musk and the Neuralink Future.jpg
Elon Musk premiering the surgical robot that implants the Neuralink brain chip

Digital consultant apps use AI to give medical consultation based on personal medical history and common medical knowledge. Users report their symptoms into the app, which uses speech recognition to compare against a database of illnesses. Babylon then offers a recommended action, taking into account the user's medical history. Entrepreneurs in healthcare have been effectively using seven business model archetypes to take AI solution[ buzzword] to the marketplace. These archetypes depend on the value generated for the target user (e.g. patient focus vs. healthcare provider and payer focus) and value capturing mechanisms (e.g. providing information or connecting stakeholders).

IFlytek launched a service robot "Xiao Man", which integrated artificial intelligence technology to identify the registered customer and provide personalized recommendations in medical areas. It also works in the field of medical imaging. Similar robots are also being made by companies such as UBTECH ("Cruzr") and Softbank Robotics ("Pepper").

The Indian startup Haptik recently developed a WhatsApp chatbot which answers questions associated with the deadly coronavirus in India. Similarly, a software platform ChatBot in partnership with medtech startup Infermedica launched COVID-19 Risk Assessment ChatBot. [128]

With the market for AI expanding constantly, large tech companies such as Apple, Google, Amazon, and Baidu all have their own AI research divisions, as well as millions of dollars allocated for acquisition of smaller AI based companies. [125] Many automobile manufacturers are beginning to use machine learning healthcare in their cars as well. [125] Companies such as BMW, GE, Tesla, Toyota, and Volvo all have new research campaigns to find ways of learning a driver's vital statistics to ensure they are awake, paying attention to the road, and not under the influence of substances. [125]

Expanding care to developing nations

Artificial intelligence continues to expand in its abilities to diagnose more people accurately in nations where fewer doctors are accessible to the public.  Many new technology companies such as SpaceX and the Raspberry Pi Foundation have enabled more developing countries to have access to computers and the internet than ever before. [129] With the increasing capabilities of AI over the internet, advanced machine learning algorithms can allow patients to get accurately diagnosed when they would previously have no way of knowing if they had a life-threatening disease or not. [129]

Using AI in developing nations that do not have the resources will diminish the need for outsourcing and can improve patient care. AI can allow for not only diagnosis of patient in areas where healthcare is scarce, but also allow for a good patient experience by resourcing files to find the best treatment for a patient. [130] The ability of AI to adjust course as it goes also allows the patient to have their treatment modified based on what works for them; a level of individualized care that is nearly non-existent in developing countries. [130]

Regulation

While research on the use of AI in healthcare aims to validate its efficacy in improving patient outcomes before its broader adoption, its use may nonetheless introduce several new types of risk to patients and healthcare providers, such as algorithmic bias, Do not resuscitate implications, and other machine morality issues. AI may also compromise the protection of patients' rights, such as the right to informed consent and the right to medical data protection. [131] These challenges of the clinical use of AI have brought about a potential need for regulations. AI studies need to be completely and transparently reported to have value to inform regulatory approval. Depending on the phase of study, international consensus-based reporting guidelines (TRIPOD+AI, [132] DECIDE-AI, [133] CONSORT-AI [134] ) have been developed to provide recommendations on the key details that need to be reported.

A man speaking at the GDPR compliance workshop at the 2019 Entrepreneurship Summit Workshop GDPR compliance at the 2019 Global Entrepreneurship Summit.jpg
A man speaking at the GDPR compliance workshop at the 2019 Entrepreneurship Summit

Currently, there are regulations pertaining to the collection of patient data. This includes policies such as the Health Insurance Portability and Accountability Act (HIPAA) and the European General Data Protection Regulation (GDPR). [135] The GDPR pertains to patients within the EU and details the consent requirements for patient data use when entities collect patient healthcare data. Similarly, HIPAA protects healthcare data from patient records in the United States. [135] In May 2016, the White House announced its plan to host a series of workshops and formation of the National Science and Technology Council (NSTC) Subcommittee on Machine Learning and Artificial Intelligence. In October 2016, the group published The National Artificial Intelligence Research and Development Strategic Plan, outlining its proposed priorities for Federally-funded AI research and development (within government and academia). The report notes a strategic R&D plan for the subfield of health information technology is in development stages.

There is concern that large language models can overwhelm people with both accurate health information and also misinformation, leading to potential challenges in public health. This calls for the need for policy and user guidance related to health information through AI. [136]

United Nations (WHO/ITU)

The joint ITU-WHO Focus Group on Artificial Intelligence for Health (FG-AI4H) has built a platform - known as the ITU-WHO AI for Health Framework - for the testing and benchmarking of AI applications in health domain. As of November 2018, eight use cases are being benchmarked, including assessing breast cancer risk from histopathological imagery, guiding anti-venom selection from snake images, and diagnosing skin lesions.

US FDA

United States Food & Drug Administration Logo of the United States Food and Drug Administration.svg
United States Food & Drug Administration

In January 2021, the US FDA published a new Action Plan, entitled Artificial Intelligence (AI) /Machine Learning (ML)-Based Software as a Medical Device (SaMD) Action Plan. [138] This plan lays out the FDA's future plans for regulation of medical devices that would include artificial intelligence in their software. There are five main actions the FDA plans to take to increase regulation: 1. Tailored Regulatory Framework for Ai/M:-based SaMD, 2. Good Machine Learning Practice (GMLP), 3. Patient-Centered Approach Incorporating Transparency to Users, 4. Regulatory Science Methods Related to Algorithm Bias & Robustness, and 5. Real-World Performance(RWP). This plan was in direct response to stakeholders' feedback on a 2019 discussion paper also published by the FDA.

According to the U.S. Department of Health and Human Services, the Office for Civil Rights (OCR) has issued guidance on the ethical use of AI in healthcare. The guidance outlines four core ethical principles that must be followed: respect for autonomy, beneficence, non-maleficence, and justice. Respect for autonomy requires that individuals have control over their own data and decisions. Beneficence requires that AI be used to do good, such as improving the quality of care and reducing health disparities. Non-maleficence requires that AI be used to do no harm, such as avoiding discrimination in decisions. Finally, justice requires that AI be used fairly, such as using the same standards for decisions no matter a person's race, gender, or income level. Moreover, as of March 2021, the OCR hired a Chief Artificial Intelligence Officer (OCAIO) to pursue the "implementation of the HHS AI strategy". [139] The OCR also has issued rules and regulations to protect the privacy of individuals’ health information. These regulations require healthcare providers to follow certain privacy rules when using AI. The OCR also requires healthcare providers to keep a record of how they use AI and to ensure that their AI systems are secure. Overall, the U.S. has taken steps to protect individuals’ privacy and ethical issues related to AI in healthcare [140]

The U.S. is not the only country to develop or initiate regulations of data privacy with AI. Other countries have implemented data protection regulations, more specifically with company privacy invasions. In Denmark, the Danish Expert Group on Data Ethics has adopted recommendations on 'Data for the Benefit of the People'. These recommendations are intended to encourage the responsible use of data in the business sector, with a focus on data processing. The recommendations include a focus on equality and non-discrimination with regard to bias in AI, as well as human dignity. The importance of human dignity is stressed, as it is said to outweigh profit and must be respected in all data processes [141]

The European Union has implemented the General Data Protection Regulation (GDPR) to protect citizens' personal data, which applies to the use of AI in healthcare. In addition, the European Commission has established guidelines to ensure the ethical development of AI, including the use of algorithms to ensure fairness and transparency. [142] With GDPR, the European Union was the first to regulate AI through data protection legislation. The Union finds privacy as a fundamental human right, it wants to prevent unconsented and secondary uses of data by private or public health facilities. By streamlining access to personal data for health research and findings, they are able to instate the right and importance of patient privacy. [142] In the United States, the Health Insurance Portability and Accountability Act (HIPAA) requires organizations to protect the privacy and security of patient information. The Centers for Medicare and Medicaid Services have also released guidelines for the development of AI-based medical applications. [143]

Ethical concerns

Data collection

In order to effectively train Machine Learning and use AI in healthcare, massive amounts of data must be gathered. Acquiring this data, however, comes at the cost of patient privacy in most cases and is not well received publicly. For example, a survey conducted in the UK estimated that 63% of the population is uncomfortable with sharing their personal data in order to improve artificial intelligence technology. [135] The scarcity of real, accessible patient data is a hindrance that deters the progress of developing and deploying more artificial intelligence in healthcare.

Furthermore, the lack of current regulations surrounding AI in the United States has generated concerns about mismanagement of patient data, such as with corporations utilizing patient data for financial gain. For example, Roche, a Swiss healthcare company, was found to have purchased healthcare data for approximately 2 million cancer patients at an estimated total cost of $1.9 billion. [144] Naturally, this generates questions of ethical concern; Is there a monetary price that can be set for data, and should it depend on its perceived value or contributions to science? Is it fair to patients to sell their data? These concerns were addressed in a survey conducted by the Pew Research Center in 2022 that asked Americans for their opinions about the increased presence of AI in their daily lives, and the survey estimated that 37% of Americans were more concerned than excited about such increased presence, with 8% of participants specifically associating their concern with "people misusing AI". [145] Ultimately, the current potential of artificial intelligence in healthcare is additionally hindered by concerns about mismanagement of data collected, especially in the United States.

Automation

A systematic review and thematic analysis in 2023 showed that most stakeholders including health professionals, patients, and the general public doubted that care involving AI could be empathetic. [146]

According to a 2019 study, AI can replace up to 35% of jobs in the UK within the next 10 to 20 years. [147] However, of these jobs, it was concluded that AI has not eliminated any healthcare jobs so far. Though if AI were to automate healthcare-related jobs, the jobs most susceptible to automation would be those dealing with digital information, radiology, and pathology, as opposed to those dealing with doctor-to-patient interaction. [147]

Automation can provide benefits alongside doctors as well. Some believe that AI may avert healthcare worker burnout and cognitive overload, so that doctors who take advantage of AI in healthcare will provide greater quality healthcare than doctors and medical establishments who do not. [148]

Recently, there have been many discussions between healthcare experts in terms of AI and elder care. In relation to elder care, AI bots have been helpful in guiding older residents living in assisted living with entertainment and company. These bots are allowing staff in the home to have more one-on-one time with each resident, but the bots are also programmed with more ability in what they are able to do; such as knowing different languages and different types of care depending on the patient's conditions. The bot is an AI machine, which means it goes through the same training as any other machine - using algorithms to parse the given data, learn from it and predict the outcome in relation to what situation is at hand [149]

Bias

Since AI makes decisions solely on the data it receives as input, it is important that this data represents accurate patient demographics. In a hospital setting, patients do not have full knowledge of how predictive algorithms are created or calibrated. Therefore, these medical establishments can unfairly code their algorithms to discriminate against minorities and prioritize profits rather than providing optimal care. [150] A recent scoping review identified 18 equity challenges along with 15 strategies that can be implemented to help address them when AI applications are developed using many-to-many mapping. [151]

There can also be unintended bias in these algorithms that can exacerbate social and healthcare inequities. [150]  Since AI's decisions are a direct reflection of its input data, the data it receives must have accurate representation of patient demographics. White males are overly represented in medical data sets. [152] Therefore, having minimal patient data on minorities can lead to AI making more accurate predictions for majority populations, leading to unintended worse medical outcomes for minority populations. [153] Collecting data from minority communities can also lead to medical discrimination. For instance, HIV is a prevalent virus among minority communities and HIV status can be used to discriminate against patients. [152] In addition to biases that may arise from sample selection, different clinical systems used to collect data may also impact AI functionality. For example, radiographic systems and their outcomes (e.g., resolution) vary by provider. Moreover, clinician work practices, such as the positioning of the patient for radiography, can also greatly influence the data and make comparability difficult. [154] However, these biases are able to be eliminated through careful implementation and a methodical collection of representative data.

A final source of bias, which has been called "label choice bias", arises when proxy measures are used to train algorithms, that build in bias against certain groups. For example, a widely used algorithm predicted health care costs as a proxy for health care needs, and used predictions to allocate resources to help patients with complex health needs. This introduced bias because Black patients have lower costs, even when they are just as unhealthy as White patients. [155] Solutions to the "label choice bias" aim to match the actual target (what the algorithm is predicting) more closely to the ideal target (what researchers want the algorithm to predict), so for the prior example, instead of predicting cost, researchers would focus on the variable of healthcare needs which is rather more significant. Adjusting the target led to almost double the number of Black patients being selected for the program.

History

Research in the 1960s and 1970s produced the first problem-solving program, or expert system, known as Dendral. [156] [157] While it was designed for applications in organic chemistry, it provided the basis for a subsequent system MYCIN, [158] considered one of the most significant early uses of artificial intelligence in medicine. [158] [159] MYCIN and other systems such as INTERNIST-1 and CASNET did not achieve routine use by practitioners, however. [160]

The 1980s and 1990s brought the proliferation of the microcomputer and new levels of network connectivity. During this time, there was a recognition by researchers and developers that AI systems in healthcare must be designed to accommodate the absence of perfect data and build on the expertise of physicians. [161] Approaches involving fuzzy set theory, [162] Bayesian networks, [163] and artificial neural networks, [164] [165] have been applied to intelligent computing systems in healthcare.

Medical and technological advancements occurring over this half-century period that have enabled the growth of healthcare-related applications of AI to include:

See also

Related Research Articles

<span class="mw-page-title-main">Health informatics</span> Computational approaches to health care

Health informatics combines communications, information technology (IT), and health care to enhance patient care and is at the forefront of the medical technological revolution. It can be viewed as a branch of engineering and applied science.

A clinical decision support system (CDSS) is a health information technology that provides clinicians, staff, patients, and other individuals with knowledge and person-specific information to help health and health care. CDSS encompasses a variety of tools to enhance decision-making in the clinical workflow. These tools include computerized alerts and reminders to care providers and patients, clinical guidelines, condition-specific order sets, focused patient data reports and summaries, documentation templates, diagnostic support, and contextually relevant reference information, among other tools. CDSSs constitute a major topic in artificial intelligence in medicine.

<span class="mw-page-title-main">Personalized medicine</span> Medical model that tailors medical practices to the individual patient

Personalized medicine, also referred to as precision medicine, is a medical model that separates people into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease. The terms personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept, though some authors and organizations differentiate between these expressions based on particular nuances. P4 is short for "predictive, preventive, personalized and participatory".

Health technology is defined by the World Health Organization as the "application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures, and systems developed to solve a health problem and improve quality of lives". This includes pharmaceuticals, devices, procedures, and organizational systems used in the healthcare industry, as well as computer-supported information systems. In the United States, these technologies involve standardized physical objects, as well as traditional and designed social means and methods to treat or care for patients.

<span class="mw-page-title-main">Computer-aided diagnosis</span> Type of diagnosis assisted by computers

Computer-aided detection (CADe), also called computer-aided diagnosis (CADx), are systems that assist doctors in the interpretation of medical images. Imaging techniques in X-ray, MRI, endoscopy, and ultrasound diagnostics yield a great deal of information that the radiologist or other medical professional has to analyze and evaluate comprehensively in a short time. CAD systems process digital images or videos for typical appearances and to highlight conspicuous sections, such as possible diseases, in order to offer input to support a decision taken by the professional.

Imaging informatics, also known as radiology informatics or medical imaging informatics, is a subspecialty of biomedical informatics that aims to improve the efficiency, accuracy, usability and reliability of medical imaging services within the healthcare enterprise. It is devoted to the study of how information about and contained within medical images is retrieved, analyzed, enhanced, and exchanged throughout the medical enterprise.

Artificial intelligence (AI) has been used in applications throughout industry and academia. In a manner analogous to electricity or computers, AI serves as a general-purpose technology. AI programes emulate perception and understanding, and are designed to adapt to new information and new situations. Machine learning has been used for various scientific and commercial purposes including language translation, image recognition, decision-making, credit scoring, and e-commerce.

Patient participation is a trend that arose in answer to medical paternalism. Informed consent is a process where patients make decisions informed by the advice of medical professionals.

<span class="mw-page-title-main">Resistance Database Initiative</span> Not-for-profit organisation

HIV Resistance Response Database Initiative (RDI) was formed in 2002 to use artificial intelligence (AI) to predict how patients will respond to HIV drugs using data from more 250,000 patients from around 50 countries around the world.

In the field of medicine, radiomics is a method that extracts a large number of features from medical images using data-characterisation algorithms. These features, termed radiomic features, have the potential to uncover tumoral patterns and characteristics that fail to be appreciated by the naked eye. The hypothesis of radiomics is that the distinctive imaging features between disease forms may be useful for predicting prognosis and therapeutic response for various cancer types, thus providing valuable information for personalized therapy. Radiomics emerged from the medical fields of radiology and oncology and is the most advanced in applications within these fields. However, the technique can be applied to any medical study where a pathological process can be imaged.

<span class="mw-page-title-main">Insilico Medicine</span> Biotechnology company

Insilico Medicine is a biotechnology company based in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery.

<span class="mw-page-title-main">Suchi Saria</span> Indian scientist

Suchi Saria is an Associate Professor of Machine Learning and Healthcare at Johns Hopkins University, where she uses big data to improve patient outcomes. She is a World Economic Forum Young Global Leader. From 2022 to 2023, she was an investment partner at AIX Ventures. AIX Ventures is a venture capital fund that invests in artificial intelligence startups.

<span class="mw-page-title-main">Merative</span> U.S. healthcare company

Merative L.P., formerly IBM Watson Health, is an American medical technology company that provides products and services that help clients facilitate medical research, clinical research, real world evidence, and healthcare services, through the use of artificial intelligence, data analytics, cloud computing, and other advanced information technology. Merative is owned by Francisco Partners, an American private equity firm headquartered in San Francisco, California. In 2022, IBM divested and spun-off their Watson Health division into Merative. As of 2023, it remains a standalone company headquartered in Ann Arbor with innovation centers in Ireland, Hyderabad, Bengaluru, and Chennai.

<span class="mw-page-title-main">Artificial intelligence of things</span>

The Artificial Intelligence of Things (AIoT) is the combination of artificial intelligence (AI) technologies with the Internet of things (IoT) infrastructure to achieve more efficient IoT operations, improve human-machine interactions and enhance data management and analytics.

Owkin is an AI biotech company that uses artificial intelligence to identify new treatments, optimize clinical trials and develop AI diagnostics. The company uses federated learning, a type of privacy preserving technology, to access multimodal patient data from academic institutions and hospitals to train its AI models for drug discovery, development, and diagnostics. Owkin has collaborated with pharmaceutical companies around the world to improve their therapeutic programs.

Personalized genomics is the human genetics-derived study of analyzing and interpreting individualized genetic information by genome sequencing to identify genetic variations compared to the library of known sequences. International genetics communities have spared no effort from the past and have gradually cooperated to prosecute research projects to determine DNA sequences of the human genome using DNA sequencing techniques. The methods that are the most commonly used are whole exome sequencing and whole genome sequencing. Both approaches are used to identify genetic variations. Genome sequencing became more cost-effective over time, and made it applicable in the medical field, allowing scientists to understand which genes are attributed to specific diseases.

Artificial intelligence in mental health is the application of artificial intelligence (AI), computational technologies and algorithms to supplement the understanding, diagnosis, and treatment of mental health disorders. AI is becoming a ubiquitous force in everyday life which can be seen through frequent operation of models like ChatGPT. Utilizing AI in the realm of mental health signifies a form of digital healthcare, in which, the goal is to increase accessibility in a world where mental health is becoming a growing concern. Prospective ideas involving AI in mental health include identification and diagnosis of mental disorders, explication of electronic health records, creation of personalized treatment plans, and predictive analytics for suicide prevention. Learning how to apply AI in healthcare proves to be a difficult task with many challenges, thus it remains rarely used as efforts to bridge gaps are deliberated.

Azra Bihorac, MD, MS (born April 2, 1965) is a Bosnian-American professor, nephrologist, and critical care intensivist who is the senior associate dean of research at the University of Florida College of Medicine and the R. Glenn Davis Professor of Medicine, Surgery, Anesthesiology, and Physiology & Functional Genomics. She co-founded the Intelligent Critical Care Center (IC3) research center at the University of Florida in 2021 with Parisa Rashidi.

<span class="mw-page-title-main">Nigam Shah</span>

Nigam Shah is a scientist, educator, and entrepreneur. His research is focused on the application of machine learning, knowledge representation, and artificial intelligence for the analysis of multiple types of health data. He is a professor of Medicine and Biomedical Data Science at Stanford University and the Chief Data Scientist at Stanford Health Care.

Statistical medicine is the science that takes help of statistical evidence for managing health and disease. The statistical evidence is generally empirical that arises directly or indirectly from observations and experiments. The validity and reliability of this evidence for medical decisions are generally assessed by appropriate statistical tools that provide confidence in using this evidence for patient management. Health is understood as the dynamic state that keeps balanced homeostasis for proper functioning of the body systems and medicine comprises steps to bring the system back on track when an aberration occurs. It includes the practices and procedures used for prevention, treatment, or relief of the ailments. Medicine becomes statistical when statistical methods are used to understand or explain the clinical evidence and their consequences, and becomes personalized when these methods are used for individual patients. These methods helps in enhancing the objectivity in clinical decisions and generally consider opposite. This is generally considered opposite to diagnosis and treatment decisions based on clinical acumen of the physicians rather than empirical evidence.

References

  1. ↑ "Developing an aging clock using deep learning on retinal images". ai.googleblog.com. 2023-04-11. Retrieved 2023-06-01.
  2. ↑ Mullainathan S, Obermeyer Z (May 2022). "Solving medicine's data bottleneck: Nightingale Open Science". Nature Medicine. 28 (5): 897–899. doi: 10.1038/s41591-022-01804-4 . PMID   35534570. S2CID   248668494.
  3. ↑ Jimma BL (2023-01-16). "Artificial intelligence in healthcare: A bibliometric analysis". Telematics and Informatics Reports. 9: 100041. doi: 10.1016/j.teler.2023.100041 .
  4. ↑ Lyakhova UA, Lyakhov PA (August 2024). "Systematic review of approaches to detection and classification of skin cancer using artificial intelligence: Development and prospects". Computers in Biology and Medicine. 178: 108742. doi:10.1016/j.compbiomed.2024.108742. PMID   38875908.
  5. ↑ Sankar H, Alagarsamy R, Lal B, Rana SS, Roychoudhury A, Agrawal A, et al. (2024). "Role of artificial intelligence in treatment planning and outcome prediction of jaw corrective surgeries by using 3-D imaging- A systematic review". Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. doi:10.1016/j.oooo.2024.09.010. PMID   39701860.
  6. ↑ Qiu Y, Cheng F (April 2024). "Artificial intelligence for drug discovery and development in Alzheimer's disease". Current Opinion in Structural Biology. 85: 102776. doi: 10.1016/j.sbi.2024.102776 . PMID   38335558.
  7. ↑ Ghanem M, Ghaith AK, Bydon M (2024). "Artificial intelligence and personalized medicine: transforming patient care". The New Era of Precision Medicine. Elsevier. pp. 131–142. doi:10.1016/b978-0-443-13963-5.00012-1. ISBN   978-0-443-13963-5 . Retrieved 2024-10-10.
  8. ↑ Snider V, Homsi K, Kusnoto B, Atsawasuwan P, Viana G, Allareddy V, et al. (May 2024). "Clinical evaluation of Artificial Intelligence Driven Remote Monitoring technology for assessment of patient oral hygiene during orthodontic treatment". American Journal of Orthodontics and Dentofacial Orthopedics. 165 (5): 586–592. doi:10.1016/j.ajodo.2023.12.008. PMID   38363256.
  9. ↑ Adams SJ, Henderson RD, Yi X, Babyn P (February 2021). "Artificial Intelligence Solutions for Analysis of X-ray Images". Canadian Association of Radiologists Journal. 72 (1): 60–72. doi: 10.1177/0846537120941671 . PMID   32757950. S2CID   221036912.
  10. ↑ Floridi L, Luetge C, Pagallo U, Schafer B, Valcke P, Vayena E, et al. (2019-09-01). "Key Ethical Challenges in the European Medical Information Framework". Minds and Machines. 29 (3): 355–371. doi: 10.1007/s11023-018-9467-4 . hdl: 2318/1728336 . ISSN   1572-8641. S2CID   49668711.
  11. ↑ Petersson L, Larsson I, Nygren JM, Nilsen P, Neher M, Reed JE, et al. (July 2022). "Challenges to implementing artificial intelligence in healthcare: a qualitative interview study with healthcare leaders in Sweden". BMC Health Services Research. 22 (1): 850. doi: 10.1186/s12913-022-08215-8 . PMC   9250210 . PMID   35778736.
  12. ↑ Andrew Wong; Erkin Otles; John P. Donnelly; Andrew Krumm; Jeffrey McCullough; Olivia DeTroyer-Cooley; Justin Pestrue; Marie Phillips; Judy Konye; Carleen Penoza; Muhammad Ghous; Karandeep Singh (June 21, 2021). "External Validation of a Widely Implemented Proprietary Sepsis Prediction Model in Hospitalized Patients". JAMA Internal Medicine. 181 (8): 1065–1070. doi:10.1001/jamainternmed.2021.2626. PMC   8218233 . PMID   34152373.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  13. ↑ Simonite T (June 21, 2021). "An Algorithm That Predicts Deadly Infections Is Often Flawed". Wired Magazine .
  14. ↑ Simonite T (October 24, 2019). "A health care algorithm offered less care to black patients". Wired Magazine .
  15. ↑ Ross C, Swetlitz I (September 5, 2017). "IBM pitched its Watson supercomputer as a revolution in cancer care. It's nowhere close". Stat .
  16. ↑ Scudellari M (March 29, 2021). "Machine Learning Faces a Reckoning in Health Research". IEEE Spectrum .
  17. ↑ Matthew B. A. McDermott, et al. (March 24, 2021). "Reproducibility in machine learning for health research: Still a ways to go". Science Translational Medicine. 13 (586). doi:10.1126/scitranslmed.abb1655. PMID   33762434.
  18. ↑ Varoquaux G, Cheplygina V (April 12, 2022). "Machine learning for medical imaging: methodological failures and recommendations for the future". npj Digital Medicine. 5 (48): 48. doi:10.1038/s41746-022-00592-y. PMC   9005663 . PMID   35413988.
  19. ↑ Sohn E (January 9, 2023). "The reproducibility issues that haunt health-care AI". Nature . 613 (7943): 402–403. doi:10.1038/d41586-023-00023-2.
  20. 1 2 Alowais SA, Alghamdi SS, Alsuhebany N, Alqahtani T, Alshaya AI, Almohareb SN, et al. (September 2023). "Revolutionizing healthcare: the role of artificial intelligence in clinical practice". BMC Medical Education. 23 (1): 689. doi: 10.1186/s12909-023-04698-z . PMC   10517477 . PMID   37740191.
  21. ↑ Liang H, Tsui BY, Ni H, Valentim CC, Baxter SL, Liu G, et al. (March 2019). "Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence". Nature Medicine. 25 (3): 433–438. doi:10.1038/s41591-018-0335-9. PMID   30742121. S2CID   59945159.
  22. ↑ Li Q, Yang X, Xu J, Guo Y, He X, Hu H, et al. (August 2023). "Early prediction of Alzheimer's disease and related dementias using real-world electronic health records". Alzheimer's & Dementia. 19 (8): 3506–3518. doi: 10.1002/alz.12967 . PMC   10976442 . PMID   36815661. S2CID   257101613.
  23. 1 2 Ayers JW, Poliak A, Dredze M, Leas EC, Zhu Z, Kelley JB, et al. (2023). "Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum". JAMA Internal Medicine. 183 (6): 589–596. doi:10.1001/jamainternmed.2023.1838. PMC   10148230 . PMID   37115527.
  24. ↑ See 'Limitations' section of Ayers et al. (2023)
  25. ↑ "Expert reaction to study comparing physician and AI chatbot responses to patient questions". Science Media Centre. April 28, 2023.
  26. ↑ Shmerling RH (March 27, 2024). "Can AI answer medical questions better than your doctor?". Harvard Health Publishing.
  27. ↑ Ramezanpour A, Beam AL, Chen JH, Mashaghi A (November 2020). "Statistical Physics for Medical Diagnostics: Learning, Inference, and Optimization Algorithms". Diagnostics. 10 (11): 972. doi: 10.3390/diagnostics10110972 . PMC   7699346 . PMID   33228143.
  28. 1 2 3 4 5 Ferrante FE (June 2005). "Evolving telemedicine/ehealth technology". Telemedicine Journal and e-Health. 11 (3): 370–383. doi:10.1089/tmj.2005.11.370. PMID   16035932.
  29. ↑ Garza-Galicia, M., Sosa, M., Low, R., & Simini, F. (2017). Enseñanza de un Programa de Ortesis Mental Clínica: Experiencia con Estudiantes de Medicina en Uruguay. Memorias Del Congreso Nacional De Ingeniería Biomédica, 4(1), 91–94. Retrieved from: http://memorias.somib.org.mx/index.php/memorias/article/view/221 Archived 2021-08-13 at the Wayback Machine
  30. 1 2 3 4 Medrano IH, Guijarro JT, Belda C, Ureña A, Salcedo I, Anke LE, et al. (2018). "Savana: Re-using Electronic Health Records with Artificial Intelligence". International Journal of Interactive Multimedia and Artificial Intelligence. 4 (7): 8–12. doi: 10.9781/ijimai.2017.03.001 . ISSN   1989-1660.
  31. 1 2 3 Eren A, Subasi A, Coskun O (February 2008). "A decision support system for telemedicine through the mobile telecommunications platform". Journal of Medical Systems. 32 (1): 31–35. doi:10.1007/s10916-007-9104-x. PMID   18333403. S2CID   11082133.
  32. ↑ Bennett CC, Doub TW, Selove R (April 2012). "EHRs connect research and practice: Where predictive modeling, artificial intelligence, and clinical decision support intersect". Health Policy and Technology. 1 (2): 105–114. arXiv: 1204.4927 . doi:10.1016/j.hlpt.2012.03.001. ISSN   2211-8837. S2CID   25022446.
  33. 1 2 Bokharaeian B, Diaz A, Chitsaz H (2016). "Enhancing Extraction of Drug-Drug Interaction from Literature Using Neutral Candidates, Negation, and Clause Dependency". PLOS ONE. 11 (10): e0163480. Bibcode:2016PLoSO..1163480B. doi: 10.1371/journal.pone.0163480 . PMC   5047471 . PMID   27695078.
  34. 1 2 3 Cai R, Liu M, Hu Y, Melton BL, Matheny ME, Xu H, et al. (February 2017). "Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports". Artificial Intelligence in Medicine. 76: 7–15. doi:10.1016/j.artmed.2017.01.004. PMC   6438384 . PMID   28363289.
  35. 1 2 Christopoulou F, Tran TT, Sahu SK, Miwa M, Ananiadou S (January 2020). "Adverse drug events and medication relation extraction in electronic health records with ensemble deep learning methods". Journal of the American Medical Informatics Association. 27 (1): 39–46. doi:10.1093/jamia/ocz101. PMC   6913215 . PMID   31390003.
  36. 1 2 Zhou D, Miao L, He Y (May 2018). "Position-aware deep multi-task learning for drug-drug interaction extraction" (PDF). Artificial Intelligence in Medicine. 87: 1–8. doi:10.1016/j.artmed.2018.03.001. PMID   29559249. S2CID   3951020.
  37. ↑ García JS (2013-04-14). Optimización del tratamiento de enfermos pluripatológicos en atención primaria UCAMI HHUU Virgen del Rocio (Report). Sevilla. Spain – via ponencias de la II Reunión de Paciente Pluripatológico y Edad Avanzada Archived.
  38. ↑ Herrero-Zazo M, Segura-Bedmar I, Martínez P, Declerck T (October 2013). "The DDI corpus: an annotated corpus with pharmacological substances and drug-drug interactions". Journal of Biomedical Informatics. 46 (5): 914–920. doi: 10.1016/j.jbi.2013.07.011 . hdl: 10016/20207 . PMID   23906817.
  39. ↑ Segura Bedmar I, Martínez P, Herrero Zazo M (June 2013). Semeval-2013 task 9: Extraction of drug-drug interactions from biomedical texts (ddiextraction 2013). Second Joint Conference on Lexical and Computational Semantics. Vol. 2. Association for Computational Linguistics. pp. 341–350.
  40. ↑ Xu B, Shi X, Yin Y, Zhao Z, Zheng W, Lin H, et al. (July 2019). "Incorporating User Generated Content for Drug Drug Interaction Extraction Based on Full Attention Mechanism". IEEE Transactions on NanoBioscience. 18 (3): 360–367. doi:10.1109/TNB.2019.2919188. PMID   31144641. S2CID   169038906.
  41. ↑ Hamet P, Tremblay J (April 2017). "Artificial intelligence in medicine". Metabolism. Insights Into the Future of Medicine: Technologies, Concepts, and Integration. 69S: S36–S40. doi:10.1016/j.metabol.2017.01.011. PMID   28126242.
  42. 1 2 Pivovarov R, Elhadad N (September 2015). "Automated methods for the summarization of electronic health records". Journal of the American Medical Informatics Association. 22 (5): 938–947. doi:10.1093/jamia/ocv032. PMC   4986665 . PMID   25882031. S2CID   1452.
  43. ↑ Yang M (October 2021). "Algorithms of Oppression: How Search Engines Reinforce RacismAlgorithms of Oppression: How Search Engines Reinforce RacismSafiya Umoja Noble NYU Press, 2018. 256 pp". Science. 374 (6567): 35–44. doi:10.1177/2057047320950636. PMC   7441483 .
  44. 1 2 3 Pouke M, Häkkilä J (December 2013). "Elderly healthcare monitoring using an avatar-based 3D virtual environment". International Journal of Environmental Research and Public Health. 10 (12): 7283–7298. doi: 10.3390/ijerph10127283 . PMC   3881167 . PMID   24351747. S2CID   18535954.
  45. ↑ Stokes F, Palmer A (October 2020). "Artificial Intelligence and Robotics in Nursing: Ethics of Caring as a Guide to Dividing Tasks Between AI and Humans". Nursing Philosophy. 21 (4): e12306. doi:10.1111/nup.12306. PMID   32609420.
  46. 1 2 Wang H, Zu Q, Chen J, Yang Z, Ahmed MA (October 2021). "Application of Artificial Intelligence in Acute Coronary Syndrome: A Brief Literature Review". Advances in Therapy. 38 (10): 5078–5086. doi:10.1007/s12325-021-01908-2. PMID   34528221. S2CID   237522871.
  47. ↑ Infante T, Cavaliere C, Punzo B, Grimaldi V, Salvatore M, Napoli C (December 2021). "Radiogenomics and Artificial Intelligence Approaches Applied to Cardiac Computed Tomography Angiography and Cardiac Magnetic Resonance for Precision Medicine in Coronary Heart Disease: A Systematic Review". Circulation: Cardiovascular Imaging. 14 (12): 1133–1146. doi: 10.1161/CIRCIMAGING.121.013025 . PMID   34915726. S2CID   245284764.
  48. ↑ Sotirakos S, Fouda B, Mohamed Razif NA, Cribben N, Mulhall C, O'Byrne A, et al. (February 2022). "Harnessing artificial intelligence in cardiac rehabilitation, a systematic review". Future Cardiology. 18 (2): 154–164. doi:10.2217/fca-2021-0010. PMID   33860679. S2CID   233258636.
  49. ↑ Chen W, Sun Q, Chen X, Xie G, Wu H, Xu C (May 2021). "Deep Learning Methods for Heart Sounds Classification: A Systematic Review". Entropy. 23 (6): 667. Bibcode:2021Entrp..23..667C. doi: 10.3390/e23060667 . PMC   8229456 . PMID   34073201.
  50. ↑ Zhao Y, Wood EP, Mirin N, Cook SH, Chunara R (October 2021). "Social Determinants in Machine Learning Cardiovascular Disease Prediction Models: A Systematic Review". American Journal of Preventive Medicine. 61 (4): 596–605. doi: 10.1016/j.amepre.2021.04.016 . PMID   34544559.
  51. ↑ He B, Kwan AC, Cho JH, Yuan N, Pollick C, Shiota T, et al. (April 2023). "Blinded, randomized trial of sonographer versus AI cardiac function assessment". Nature. 616 (7957): 520–524. Bibcode:2023Natur.616..520H. doi:10.1038/s41586-023-05947-3. PMC   10115627 . PMID   37020027.
  52. ↑ Mullainathan S, Obermeyer Z (2022). ""Diagnosing Physician Error: A Machine Learning Approach to Low-Value Health Care"". The Quarterly Journal of Economics. 137 (2): 679–727. doi:10.1093/qje/qjab046 – via Oxford Academic.
  53. ↑ Bax M, Thorpe J, Romanov V (December 2023). "The future of personalized cardiovascular medicine demands 3D and 4D printing, stem cells, and artificial intelligence". Frontiers in Sensors. 4. doi: 10.3389/fsens.2023.1294721 . ISSN   2673-5067.
  54. ↑ Hibler BP, Qi Q, Rossi AM (March 2016). "Current state of imaging in dermatology". Seminars in Cutaneous Medicine and Surgery. 35 (1): 2–8. doi: 10.12788/j.sder.2016.001 (inactive 23 December 2024). PMID   26963110.{{cite journal}}: CS1 maint: DOI inactive as of December 2024 (link)
  55. ↑ Chan S, Reddy V, Myers B, Thibodeaux Q, Brownstone N, Liao W (June 2020). "Machine Learning in Dermatology: Current Applications, Opportunities, and Limitations". Dermatology and Therapy. 10 (3): 365–386. doi:10.1007/s13555-020-00372-0. PMC   7211783 . PMID   32253623.
  56. ↑ Han SS, Moon IJ, Lim W, Suh IS, Lee SY, Na JI, et al. (January 2020). "Keratinocytic Skin Cancer Detection on the Face Using Region-Based Convolutional Neural Network". JAMA Dermatology. 156 (1): 29–37. doi:10.1001/jamadermatol.2019.3807. PMC   6902187 . PMID   31799995.
  57. ↑ Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. (February 2017). "Dermatologist-level classification of skin cancer with deep neural networks". Nature. 542 (7639): 115–118. Bibcode:2017Natur.542..115E. doi:10.1038/nature21056. PMC   8382232 . PMID   28117445. S2CID   3767412.
  58. ↑ Noyan MA, Durdu M, Eskiocak AH (October 2020). "TzanckNet: a convolutional neural network to identify cells in the cytology of erosive-vesiculobullous diseases". Scientific Reports. 10 (1): 18314. doi: 10.1038/s41598-020-75546-z . PMC   7591506 . PMID   33110197.
  59. ↑ Adamson AS, Smith A (November 2018). "Machine Learning and Health Care Disparities in Dermatology". JAMA Dermatology. 154 (11): 1247–1248. doi:10.1001/jamadermatol.2018.2348. PMID   30073260. S2CID   51907489.
  60. ↑ "Computer learns to detect skin cancer more accurately than doctors". The Guardian. 29 May 2018.
  61. 1 2 Haggenmüller S, Maron RC, Hekler A, Utikal JS, Barata C, Barnhill RL, et al. (October 2021). "Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts". European Journal of Cancer. 156: 202–216. doi: 10.1016/j.ejca.2021.06.049 . PMID   34509059.
  62. ↑ Han SS, Moon IJ, Kim SH, Na JI, Kim MS, Park GH, et al. (November 2020). "Assessment of deep neural networks for the diagnosis of benign and malignant skin neoplasms in comparison with dermatologists: A retrospective validation study". PLOS Medicine. 17 (11): e1003381. doi: 10.1371/journal.pmed.1003381 . PMC   7688128 . PMID   33237903.
  63. ↑ Patcas R, Bernini DA, Volokitin A, Agustsson E, Rothe R, Timofte R (January 2019). "Applying artificial intelligence to assess the impact of orthognathic treatment on facial attractiveness and estimated age". International Journal of Oral and Maxillofacial Surgery. 48 (1): 77–83. doi: 10.1016/j.ijom.2018.07.010 . PMID   30087062.
  64. ↑ Patcas R, Timofte R, Volokitin A, Agustsson E, Eliades T, Eichenberger M, et al. (August 2019). "Facial attractiveness of cleft patients: a direct comparison between artificial-intelligence-based scoring and conventional rater groups". European Journal of Orthodontics. 41 (4): 428–433. doi:10.1093/ejo/cjz007. hdl: 20.500.11850/377316 . PMID   30788496. S2CID   73507799.
  65. 1 2 Cao JS, Lu ZY, Chen MY, Zhang B, Juengpanich S, Hu JH, et al. (April 2021). "Artificial intelligence in gastroenterology and hepatology: Status and challenges". World Journal of Gastroenterology. 27 (16): 1664–1690. doi: 10.3748/wjg.v27.i16.1664 . PMC   8072192 . PMID   33967550.
  66. ↑ "Artificial intelligence: 10 promising interventions for healthcare". NIHR Evidence. National Institute for Health and Care Research. 28 July 2023. doi:10.3310/nihrevidence_59502.
  67. ↑ Iacucci M, Parigi TL, Del Amor R, Meseguer P, Mandelli G, Bozzola A, et al. (June 2023). "Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative Colitis". Gastroenterology. 164 (7): 1180–1188.e2. doi:10.1053/j.gastro.2023.02.031. hdl: 2434/962515 . PMID   36871598.
  68. ↑ Kim HY, Cho GJ, Kwon HS (January 2023). "Applications of artificial intelligence in obstetrics". Ultrasonography. 42 (1): 2–9. doi:10.14366/usg.22063. PMC   9816710 . PMID   36588179.
  69. 1 2 Tran NK, Albahra S, May L, Waldman S, Crabtree S, Bainbridge S, et al. (December 2021). "Evolving Applications of Artificial Intelligence and Machine Learning in Infectious Diseases Testing". Clinical Chemistry. 68 (1): 125–133. doi:10.1093/clinchem/hvab239. PMC   9383167 . PMID   34969102.
  70. ↑ Farhat F, Sohail SS, Alam MT, Ubaid S, Ashhad M, Madsen DØ (2023-11-08). "COVID-19 and beyond: leveraging artificial intelligence for enhanced outbreak control". Frontiers in Artificial Intelligence. 6: 1266560. doi: 10.3389/frai.2023.1266560 . PMC   10663297 . PMID   38028660.
  71. ↑ Mann S, Berdahl CT, Baker L, Girosi F (October 2022). Pani D (ed.). "Artificial intelligence applications used in the clinical response to COVID-19: A scoping review". PLOS Digital Health. 1 (10): e0000132. doi: 10.1371/journal.pdig.0000132 . PMC   9931281 . PMID   36812557.
  72. ↑ "AI could make health care fairer—by helping us believe what patients say". MIT Technology Review. Retrieved 2023-06-03.
  73. ↑ Pierson E, Cutler DM, Leskovec J, Mullainathan S, Obermeyer Z (January 2021). "An algorithmic approach to reducing unexplained pain disparities in underserved populations". Nature Medicine. 27 (1): 136–140. doi:10.1038/s41591-020-01192-7. PMID   33442014. S2CID   256839494.
  74. ↑ Khojaste-Sarakhsi M, Haghighi SS, Ghomi SM, Marchiori E (August 2022). "Deep learning for Alzheimer's disease diagnosis: A survey". Artificial Intelligence in Medicine. 130 (933–3657): 102332. doi:10.1016/j.artmed.2022.102332. PMID   35809971. S2CID   249633553.
  75. ↑ "About ADNI". 2017. Retrieved October 30, 2023.
  76. ↑ Nguyen HD, Clément M, Mansencal B, Coupé P (21 September 2021). Deep Grading Based on Collective Artificial Intelligence for AD Diagnosis and Prognosis. Interpretability of Machine Intelligence in Medical Image Computing, and Topological Data Analysis and Its Applications for Medical Data. Springer, Cham. pp. 24–33. arXiv: 2211.15192 . doi:10.1007/978-3-030-87444-5_3.
  77. ↑ Qu C, Zou Y, Ma Y, Chen Q, Luo J, Fan H, et al. (21 April 2022). "Diagnostic Performance of Generative Adversarial Network-Based Deep Learning Methods for Alzheimer's Disease: A Systematic Review and Meta-Analysis". Frontiers in Aging Neuroscience. 14: 841696. doi: 10.3389/fnagi.2022.841696 . PMC   9068970 . PMID   35527734.
  78. ↑ Fisher CK, Smith AM, Walsh JR (September 2019). "Machine learning for comprehensive forecasting of Alzheimer's Disease progression". Scientific Reports. 9 (1): 13622. arXiv: 1807.03876 . Bibcode:2019NatSR...913622F. doi:10.1038/s41598-019-49656-2. PMC   6754403 . PMID   31541187.
  79. ↑ Bhinder B, Gilvary C, Madhukar NS, Elemento O (April 2021). "Artificial Intelligence in Cancer Research and Precision Medicine". Cancer Discovery. 11 (4): 900–915. doi:10.1158/2159-8290.CD-21-0090. PMC   8034385 . PMID   33811123.
  80. ↑ Majumder A, Sen D (October 2021). "Artificial intelligence in cancer diagnostics and therapy: current perspectives". Indian Journal of Cancer. 58 (4): 481–492. doi: 10.4103/ijc.IJC_399_20 . PMID   34975094. S2CID   240522128.
  81. ↑ Kobie N (1 January 2020). "DeepMind's new AI can spot breast cancer just as well as your doctor". Wired. Retrieved 1 January 2020.
  82. ↑ McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H, et al. (January 2020). "International evaluation of an AI system for breast cancer screening". Nature. 577 (7788): 89–94. Bibcode:2020Natur.577...89M. doi:10.1038/s41586-019-1799-6. hdl: 10044/1/76203 . PMID   31894144. S2CID   209523468.
  83. ↑ McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H, et al. (January 2020). "International evaluation of an AI system for breast cancer screening". Nature. 577 (7788): 89–94. Bibcode:2020Natur.577...89M. doi:10.1038/s41586-019-1799-6. hdl: 10044/1/76203 . PMID   31894144.
  84. ↑ Heaven WD (November 12, 2020). "AI is wrestling with a replication crisis". MIT Technology Review .
  85. ↑ "Artificial intelligence identifies prostate cancer with near-perfect accuracy". EurekAlert!. 27 July 2020. Retrieved 29 July 2020.
  86. ↑ Pantanowitz L, Quiroga-Garza GM, Bien L, Heled R, Laifenfeld D, Linhart C, et al. (August 2020). "An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study". The Lancet. Digital Health. 2 (8): e407–e416. doi: 10.1016/S2589-7500(20)30159-X . PMID   33328045.
  87. ↑ Arthur A, Orton MR, Emsley R, Vit S, Kelly-Morland C, Strauss D, et al. (November 2023). "A CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis". The Lancet. Oncology. 24 (11): 1277–1286. doi:10.1016/S1470-2045(23)00462-X. PMC   10618402 . PMID   37922931.
  88. ↑ "Scientists excited by AI tool that grades severity of rare cancer". BBC News. 2023-11-01. Retrieved 2023-11-12.
  89. ↑ Ravindran S (April 2019). "How artificial intelligence is helping to prevent blindness". Nature. doi:10.1038/d41586-019-01111-y. PMID   32269369. S2CID   146005413.
  90. ↑ Office of the Commissioner (2020-03-24). "FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems". FDA. Retrieved 2023-02-11.
  91. ↑ Han JH (August 2022). "Artificial Intelligence in Eye Disease: Recent Developments, Applications, and Surveys". Diagnostics. 12 (8): 1927. doi: 10.3390/diagnostics12081927 . PMC   9406878 . PMID   36010277.
  92. ↑ Lourenço BC, Guimarães-Teixeira C, Flores BC, Miranda-Gonçalves V, Guimarães R, Cantante M, et al. (February 2022). "Ki67 and LSD1 Expression in Testicular Germ Cell Tumors Is Not Associated with Patient Outcome: Investigation Using a Digital Pathology Algorithm". Life. 12 (2): 264. Bibcode:2022Life...12..264L. doi: 10.3390/life12020264 . PMC   8875543 . PMID   35207551.
    - Figure 2 - available via license: Creative Commons Attribution 4.0 International
  93. 1 2 3 4 5 Försch S, Klauschen F, Hufnagl P, Roth W (March 2021). "Artificial Intelligence in Pathology". Deutsches Ärzteblatt International. 118 (12): 194–204. doi:10.3238/arztebl.m2021.0011. PMC   8278129 . PMID   34024323.
  94. ↑ Steiner DF, MacDonald R, Liu Y, Truszkowski P, Hipp JD, Gammage C, et al. (December 2018). "Impact of Deep Learning Assistance on the Histopathologic Review of Lymph Nodes for Metastatic Breast Cancer". The American Journal of Surgical Pathology. 42 (12): 1636–1646. doi:10.1097/PAS.0000000000001151. PMC   6257102 . PMID   30312179.
  95. ↑ Ho J, Ahlers SM, Stratman C, Aridor O, Pantanowitz L, Fine JL, et al. (2014). "Can digital pathology result in cost savings? A financial projection for digital pathology implementation at a large integrated health care organization". Journal of Pathology Informatics. 5 (1): 33. doi: 10.4103/2153-3539.139714 . PMC   4168664 . PMID   25250191.
  96. ↑ Jurmeister P, Bockmayr M, Seegerer P, Bockmayr T, Treue D, Montavon G, et al. (September 2019). "Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases". Science Translational Medicine. 11 (509): eaaw8513. doi: 10.1126/scitranslmed.aaw8513 . PMID   31511427. S2CID   202564269.
  97. ↑ Mistry P (September 2019). "Artificial intelligence in primary care". The British Journal of General Practice. 69 (686): 422–423. doi:10.3399/bjgp19X705137. PMC   6715470 . PMID   31467001.
  98. ↑ Blease C, Kaptchuk TJ, Bernstein MH, Mandl KD, Halamka JD, DesRoches CM (March 2019). "Artificial Intelligence and the Future of Primary Care: Exploratory Qualitative Study of UK General Practitioners' Views". Journal of Medical Internet Research. 21 (3): e12802. doi: 10.2196/12802 . PMC   6446158 . PMID   30892270. S2CID   59175658.
  99. ↑ Liyanage H, Liaw ST, Jonnagaddala J, Schreiber R, Kuziemsky C, Terry AL, et al. (August 2019). "Artificial Intelligence in Primary Health Care: Perceptions, Issues, and Challenges". Yearbook of Medical Informatics. 28 (1): 41–46. doi:10.1055/s-0039-1677901. PMC   6697547 . PMID   31022751.
  100. ↑ Herter WE, Khuc J, Cinà G, Knottnerus BJ, Numans ME, Wiewel MA, et al. (May 2022). "Impact of a Machine Learning-Based Decision Support System for Urinary Tract Infections: Prospective Observational Study in 36 Primary Care Practices". JMIR Medical Informatics. 10 (5): e27795. doi: 10.2196/27795 . PMC   9118012 . PMID   35507396. S2CID   246819392.
  101. ↑ Graham S, Depp C, Lee EE, Nebeker C, Tu X, Kim HC, et al. (November 2019). "Artificial Intelligence for Mental Health and Mental Illnesses: an Overview". Current Psychiatry Reports. 21 (11): 116. doi:10.1007/s11920-019-1094-0. PMC   7274446 . PMID   31701320.
  102. ↑ Chekroud AM, Bondar J, Delgadillo J, Doherty G, Wasil A, Fokkema M, et al. (June 2021). "The promise of machine learning in predicting treatment outcomes in psychiatry". World Psychiatry. 20 (2): 154–170. doi:10.1002/wps.20882. PMC   8129866 . PMID   34002503.
  103. ↑ Fulmer R, Joerin A, Gentile B, Lakerink L, Rauws M (December 2018). "Using Psychological Artificial Intelligence (Tess) to Relieve Symptoms of Depression and Anxiety: Randomized Controlled Trial". JMIR Mental Health. 5 (4): e64. doi: 10.2196/mental.9782 . PMC   6315222 . PMID   30545815.
  104. ↑ Coppersmith G, Leary R, Crutchley P, Fine A (January 2018). "Natural Language Processing of Social Media as Screening for Suicide Risk". Biomedical Informatics Insights. 10: 1178222618792860. doi:10.1177/1178222618792860. PMC   6111391 . PMID   30158822.
  105. ↑ Brunn M, Diefenbacher A, Courtet P, Genieys W (August 2020). "The Future is Knocking: How Artificial Intelligence Will Fundamentally Change Psychiatry". Academic Psychiatry. 44 (4): 461–466. doi: 10.1007/s40596-020-01243-8 . PMID   32424706. S2CID   218682746.
  106. ↑ Rutledge RB, Chekroud AM, Huys QJ (April 2019). "Machine learning and big data in psychiatry: toward clinical applications". Current Opinion in Neurobiology. Machine Learning, Big Data, and Neuroscience. 55: 152–159. doi:10.1016/j.conb.2019.02.006. PMID   30999271. S2CID   115202826.
  107. ↑ Crimmins T (2023-05-30). "'This robot causes harm': National Eating Disorders Association's new chatbot advises people with disordering eating to lose weight". The Daily Dot. Retrieved 2023-06-02.
  108. ↑ Knight T (May 31, 2023). "Eating disorder helpline fires AI for harmful advice after sacking humans".
  109. ↑ Aratani L (2023-05-31). "US eating disorder helpline takes down AI chatbot over harmful advice". The Guardian. ISSN   0261-3077 . Retrieved 2023-06-01.
  110. 1 2 3 4 Pisarchik AN, Maksimenko VA, Hramov AE (October 2019). "From Novel Technology to Novel Applications: Comment on "An Integrated Brain-Machine Interface Platform With Thousands of Channels" by Elon Musk and Neuralink". Journal of Medical Internet Research. 21 (10): e16356. doi: 10.2196/16356 . PMC   6914250 . PMID   31674923. S2CID   207818415.
  111. 1 2 Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJ (August 2018). "Artificial intelligence in radiology". Nature Reviews. Cancer. 18 (8): 500–510. doi:10.1038/s41568-018-0016-5. PMC   6268174 . PMID   29777175.
  112. ↑ Liu X, Faes L, Kale AU, Wagner SK, Fu DJ, Bruynseels A, et al. (October 2019). "A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis". The Lancet. Digital Health. 1 (6): e271–e297. doi: 10.1016/S2589-7500(19)30123-2 . PMID   33323251. S2CID   204037561.
  113. ↑ Georgescu MI, Ionescu RT, Miron AI, Savencu O, Ristea NC, Verga N, et al. (2023). Multimodal Multi-Head Convolutional Attention With Various Kernel Sizes for Medical Image Super-Resolution (Report). IEEE/CVF Winter Conference on Applications of Computer Vision. pp. 2195–2205.
  114. ↑ Richardson ML, Garwood ER, Lee Y, Li MD, Lo HS, Nagaraju A, et al. (September 2021). "Noninterpretive Uses of Artificial Intelligence in Radiology". Academic Radiology. 28 (9): 1225–1235. doi:10.1016/j.acra.2020.01.012. PMID   32059956.
  115. ↑ Seifert R, Weber M, Kocakavuk E, Rischpler C, Kersting D (March 2021). "Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives". Seminars in Nuclear Medicine. 51 (2): 170–177. doi:10.1053/j.semnuclmed.2020.08.003. PMID   33509373. S2CID   224863373.
  116. ↑ Pacilè S, Lopez J, Chone P, Bertinotti T, Grouin JM, Fillard P (November 2020). "Improving Breast Cancer Detection Accuracy of Mammography with the Concurrent Use of an Artificial Intelligence Tool". Radiology: Artificial Intelligence. 2 (6): e190208. doi:10.1148/ryai.2020190208. PMC   8082372 . PMID   33937844.
  117. ↑ Uzialko A (21 February 2023). "How Artificial Intelligence Is Transforming Business". Business News Daily. Retrieved 2023-08-11.
  118. ↑ Gülen K (6 September 2022). "Emerging Technologies: Artificial Intelligence Is Shaping Every Industry". Dataconomy Media GmbH. Retrieved 2023-08-11.
  119. ↑ Frankenfield J (24 April 2023). Scott G (ed.). "Artificial Intelligence: What It Is and How It Is Used". Investopedia. Retrieved 2023-08-11.
  120. ↑ Vora LK, Gholap AD, Jetha K, Thakur RR, Solanki HK, Chavda VP (July 2023). "Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design". Pharmaceutics. 15 (7): 1916. doi: 10.3390/pharmaceutics15071916 . PMC   10385763 . PMID   37514102.
  121. ↑ Khan O, Parvez M, Kumari P, Parvez S, Ahmad S (June 2023). "The future of pharmacy: How AI is revolutionizing the industry". Intelligent Pharmacy. 1 (1): 32–40. doi: 10.1016/j.ipha.2023.04.008 . ISSN   2949-866X. S2CID   258625020.
  122. ↑ Chaudhary S, Muthudoss P, Madheswaran T, Paudel A, Gaikwad V (2023). "Artificial intelligence (AI) in drug product designing, development, and manufacturing". A Handbook of Artificial Intelligence in Drug Delivery. Elsevier. pp. 395–442. doi:10.1016/b978-0-323-89925-3.00015-0. ISBN   978-0-323-89925-3 . Retrieved 2023-12-19.
  123. ↑ "AI for Pharmacist #6 Identifying AI Education Needs in Pharmaceutical Sciences". www.linkedin.com. Retrieved 2023-12-19.
  124. ↑ Vora LK, Gholap AD, Jetha K, Thakur RR, Solanki HK, Chavda VP (2023-07-10). "Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design". Pharmaceutics. 15 (7): 1916. doi: 10.3390/pharmaceutics15071916 . ISSN   1999-4923. PMC   10385763 . PMID   37514102.
  125. 1 2 3 4 Quan XI, Sanderson J (December 2018). "Understanding the Artificial Intelligence Business Ecosystem". IEEE Engineering Management Review. 46 (4): 22–25. doi:10.1109/EMR.2018.2882430. ISSN   0360-8581. S2CID   59525052.
  126. ↑ Tung L (September 20, 2016). "Microsoft's next big AI project? Helping 'solve' cancer". ZDNET. Retrieved 2024-01-28.
  127. ↑ McCarthy J (2016-05-31). "Intel Capital invests $10 million in medical artificial intelligence". Healthcare IT News. Retrieved 2024-01-28.
  128. ↑ Carpenter J (2021-04-07). "Meet the Chatbots That Might Manage Your Money One Day". Wall Street Journal. ISSN   0099-9660 . Retrieved 2022-06-30.
  129. 1 2 Abou-Zahra S, Brewer J, Cooper M (2018-04-23). "Artificial Intelligence (AI) for Web Accessibility". Proceedings of the 15th International Web for All Conference. W4A '18. Lyon, France: Association for Computing Machinery. pp. 1–4. doi:10.1145/3192714.3192834. ISBN   978-1-4503-5651-0. S2CID   49863409.
  130. 1 2 Guo J, Li B (2018-08-01). "The Application of Medical Artificial Intelligence Technology in Rural Areas of Developing Countries". Health Equity. 2 (1): 174–181. doi:10.1089/heq.2018.0037. PMC   6110188 . PMID   30283865.
  131. ↑ Van Kolfschooten H (2022-02-01). "EU regulation of artificial intelligence: Challenges for patients' rights" (PDF). Common Market Law Review. 59 (1): 81–112. doi:10.54648/COLA2022005. ISSN   0165-0750. S2CID   248591427.
  132. ↑ Collins GS, Moons KG, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. (April 2024). "TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods". BMJ. 385: e078378. doi:10.1136/bmj-2023-078378. PMC   11019967 . PMID   38626948.
  133. ↑ Vasey B, Nagendran M, Campbell B, Clifton DA, Collins GS, Denaxas S, et al. (May 2022). "Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI". BMJ. 377: e070904. doi:10.1136/bmj-2022-070904. PMC   9116198 . PMID   35584845.
  134. ↑ Liu X, Cruz Rivera S, Moher D, Calvert MJ, Denniston AK (September 2020). "Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension". Nature Medicine. 26 (9): 1364–1374. doi:10.1038/s41591-020-1034-x. PMC   7598943 . PMID   32908283.
  135. 1 2 3 Lacassie E, Marquet P, Martin-Dupont S, Gaulier JM, Lachâtre G (September 2000). "A non-fatal case of intoxication with foxglove, documented by means of liquid chromatography-electrospray-mass spectrometry". Journal of Forensic Sciences. 45 (5): 1154–1158. doi:10.1520/JFS14845J. PMID   11005196.
  136. ↑ De Angelis L, Baglivo F, Arzilli G, Privitera GP, Ferragina P, Tozzi AE, et al. (2023-04-25). "ChatGPT and the rise of large language models: the new AI-driven infodemic threat in public health". Frontiers in Public Health. 11: 1166120. doi: 10.3389/fpubh.2023.1166120 . PMC   10166793 . PMID   37181697.
  137. ↑ Office of the Commissioner (2022-11-30). "About FDA". FDA. Retrieved 2023-04-08.
  138. ↑ "Artificial Intelligence and Machine Learning in Software as a Medical Device". FDA. 2023-10-20.
  139. ↑ "HHS Artificial Intelligence (AI) Strategy". www.hhs.gov. 2021-12-22. Retrieved 2023-11-25.
  140. ↑ "Civil Rights for Providers of Health Care and Human Services". hhs.gov. Office for Civil Rights. 2015-09-05. Retrieved 2022-12-17.
  141. ↑ "Cambridge Core - Journals & Books Online | Cambridge University Press". Cambridge Core. Retrieved 2022-12-17.
  142. 1 2 Forcier MB, Gallois H, Mullan S, Joly Y (October 2019). "Integrating artificial intelligence into health care through data access: can the GDPR act as a beacon for policymakers?". Journal of Law and the Biosciences. 6 (1): 317–335. doi:10.1093/jlb/lsz013. PMC   6813940 . PMID   31666972.
  143. ↑ "Sharing and Utilizing Health Data for AI Applications". hhs.gov.
  144. ↑ Mudgal KS, Das N (2020-11-01). "The ethical adoption of artificial intelligence in radiology". BJR Open. 2 (1): 20190020. doi:10.1259/bjro.20190020. PMC   7605209 . PMID   33178959.
  145. ↑ Rainie L, Funk C, Anderson M, Tyson A (2022-03-17). "1. How Americans think about artificial intelligence". Pew Research Center. Retrieved 2024-06-11.
  146. ↑ Vo V, Chen G, Aquino YS, Carter SM, Do QN, Woode ME (December 2023). "Multi-stakeholder preferences for the use of artificial intelligence in healthcare: A systematic review and thematic analysis". Social Science & Medicine. 338 (1): 116357. doi: 10.1016/j.socscimed.2023.116357 . PMID   37949020.
  147. 1 2 Davenport T, Kalakota R (June 2019). "The potential for artificial intelligence in healthcare". Future Healthcare Journal. 6 (2): 94–98. doi:10.7861/futurehosp.6-2-94. PMC   6616181 . PMID   31363513.
  148. ↑ U.S News Staff (2018-09-20). "Artificial Intelligence Continues to Change Health Care". US News.
  149. ↑ Savage N (January 2022). "Robots rise to meet the challenge of caring for old people". Nature. 601 (7893): S8–S10. Bibcode:2022Natur.601S...8S. doi:10.1038/d41586-022-00072-z. PMID   35046591. S2CID   246064292.
  150. 1 2 Baric-Parker J, Anderson EE (November 2020). "Patient Data-Sharing for AI: Ethical Challenges, Catholic Solutions". The Linacre Quarterly. 87 (4): 471–481. doi:10.1177/0024363920922690. PMC   7551527 . PMID   33100395.
  151. ↑ Mann S, Berdahl CT, Baker L, Girosi F (October 2022). "Artificial intelligence applications used in the clinical response to COVID-19: A scoping review". PLOS Digital Health. 1 (10): e0000132. doi: 10.2196/42936 . PMC   11041459 . PMID   38875587. S2CID   256681439.
  152. 1 2 Nordling L (September 2019). "A fairer way forward for AI in health care". Nature. 573 (7775): S103–S105. Bibcode:2019Natur.573S.103N. doi: 10.1038/d41586-019-02872-2 . PMID   31554993. S2CID   202749329.
  153. ↑ Reddy S, Allan S, Coghlan S, Cooper P (March 2020). "A governance model for the application of AI in health care". Journal of the American Medical Informatics Association. 27 (3): 491–497. doi:10.1093/jamia/ocz192. PMC   7647243 . PMID   31682262.
  154. ↑ Pumplun L, Fecho M, Wahl N, Peters F, Buxmann P (October 2021). "Adoption of Machine Learning Systems for Medical Diagnostics in Clinics: Qualitative Interview Study". Journal of Medical Internet Research. 23 (10): e29301. doi: 10.2196/29301 . PMC   8556641 . PMID   34652275. S2CID   238990562.
  155. ↑ Evans M, Mathews AW (2019-10-24). "Researchers Find Racial Bias in Hospital Algorithm". Wall Street Journal. ISSN   0099-9660 . Retrieved 2023-06-03.
  156. ↑ Lindsay RK, Buchanan BG, Feigenbaum EA, Lederberg J (1993). "DENDRAL: a case study of the first expert system for scientific hypothesis formation". Artificial Intelligence. 61 (2): 209–261. doi:10.1016/0004-3702(93)90068-m. hdl: 2027.42/30758 .
  157. ↑ Lea AS (2023). Digitizing Diagnosis: Medicine, Minds, and Machines in Twentieth-Century America. Johns Hopkins University Press. pp. 1–256. ISBN   978-1-4214-4681-3.
  158. 1 2 Clancey WJ, Shortliffe EH (1984). Readings in medical artificial intelligence: the first decade. Addison-Wesley Longman Publishing Co., Inc.
  159. ↑ Bruce G, Buchanan BG, Shortliffe ED (1984). Rule-based expert systems: the MYCIN experiments of the Stanford Heuristic Programming Project.
  160. ↑ Duda RO, Shortliffe EH (April 1983). "Expert Systems Research". Science. 220 (4594): 261–268. Bibcode:1983Sci...220..261D. doi:10.1126/science.6340198. PMID   6340198.
  161. ↑ Miller RA (1994). "Medical diagnostic decision support systems--past, present, and future: a threaded bibliography and brief commentary". Journal of the American Medical Informatics Association. 1 (1): 8–27. doi:10.1136/jamia.1994.95236141. PMC   116181 . PMID   7719792.
  162. ↑ Adlassnig KP (July 1980). "A fuzzy logical model of computer-assisted medical diagnosis". Methods of Information in Medicine. 19 (3): 141–148. doi:10.1055/s-0038-1636674. PMID   6997678.
  163. ↑ Reggia JA, Peng Y (September 1987). "Modeling diagnostic reasoning: a summary of parsimonious covering theory". Computer Methods and Programs in Biomedicine. 25 (2): 125–134. doi:10.1016/0169-2607(87)90048-4. PMC   2244953 . PMID   3315427.
  164. ↑ Baxt WG (December 1991). "Use of an artificial neural network for the diagnosis of myocardial infarction". Annals of Internal Medicine. 115 (11): 843–848. doi:10.7326/0003-4819-115-11-843. PMID   1952470.
  165. ↑ Maclin PS, Dempsey J, Brooks J, Rand J (February 1991). "Using neural networks to diagnose cancer". Journal of Medical Systems. 15 (1): 11–19. doi:10.1007/bf00993877. PMID   1748845. S2CID   10189561.
  166. ↑ Koomey J, Berard S, Sanchez M, Wong H (March 2010). "Implications of historical trends in the electrical efficiency of computing". IEEE Annals of the History of Computing. 33 (3): 46–54. CiteSeerX   10.1.1.323.9505 . doi:10.1109/MAHC.2010.28. S2CID   8305701.
  167. ↑ Barnes B, Dupré J (2009). Genomes and what to make of them. University of Chicago Press. ISBN   9780226172965.[ page needed ]
  168. ↑ Jha AK, DesRoches CM, Campbell EG, Donelan K, Rao SR, Ferris TG, et al. (April 2009). "Use of electronic health records in U.S. hospitals". The New England Journal of Medicine. 360 (16): 1628–1638. doi: 10.1056/NEJMsa0900592 . PMID   19321858. S2CID   19914056.
  169. ↑ Banko M, Brill E (July 2001). "Scaling to very very large corpora for natural language disambiguation" (PDF). Proceedings of the 39th Annual Meeting on Association for Computational Linguistics. Association for Computational Linguistics: 26–33. Archived from the original (PDF) on 2019-04-07. Retrieved 2019-04-07.
  170. ↑ Dougherty G (2009). Digital image processing for medical applications. Cambridge University Press.
  171. ↑ "Artificial Intelligence and Machine Learning for Healthcare". Sigmoidal. 21 December 2017. Archived from the original on 17 August 2020. Retrieved 26 March 2018.
  172. ↑ Hu L, Li L (December 2022). "Using Tree-Based Machine Learning for Health Studies: Literature Review and Case Series". International Journal of Environmental Research and Public Health. 19 (23): 16080. doi: 10.3390/ijerph192316080 . PMC   9736500 . PMID   36498153.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.